/

Società

Ka

Non verificato

Kashiv BioSciences, LLC and Amneal Pharmaceuticals, Inc. and Alvotech and Advanz Pharma

Di cosa scriviamo

BiotecnologiaFarmaceuticaHIV, AIDS e malattie autoimmuniIgiene alimentareIndustria

1 comunicati stampa

Guarda tutti i comunicati

06/10/2025

Salute

Igiene alimentare

HIV, AIDS e malattie autoimmuni

Sanità

Farmaceutica

Biotecnologia

Industria

Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab)

Fonte

Kashiv BioSciences, LLC and Amneal Pharmaceuticals, Inc. and Alvotech and Advanz Pharma

Emittente

1.00

0

Seguaci

0

Compatibilità

0